Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomized controlled trial. Lancet 2017; 390: 959–968.

Published: 28th November 2017

Authors: de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, Maljaars JP, Cilissen M et al.


A total of 909 patients were randomized to standard care, or a telemonitoring system. After twelve months, the mean number of outpatient visits required was reduced in the telemonitoring group (1.55 versus 2.34, P<0.0001), as was the number of hospital admissions (0.05 versus 0.1, P=0.046). Quality of life measures were similar.

Pubmed Link

Your comments